Pharma Litigator Leaves Fitzpatrick Cella, Joins Sidley

Law360, New York (February 22, 2005, 12:00 AM EST) -- Pharma and biotech patent litigator Thomas Beck has left Fitzpatrick Cella Harper & Scinto to join Sidley Austin Brown & Wood LLP as a partner.

Beck, who had been a partner with Fitzpatrick Cella, will continue to focus on complex pharmaceutical and biotechnology patent litigation matters at his new firm’s New York office, Sidley said.

“A lawyer with Tom’s combination of extensive patent litigation experience and keen knowledge of intricate biological and chemical processes is uncommon, and we are delighted that he will bring them to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.